protein tyrosine phosphatase, receptor type, c polypeptide
CD45 antigen
T200 glycoprotein
T200 leukocyte common antigen
leukocyte-common antigen
protein tyrosine phosphatase, receptor type, C
receptor type
C
Background Information
CD45 is a receptor-tyrosine phosphatase required for antigen-induced signaling in T-cells and B-cells; its substrates are unknown. Interestingly, it associates with several Src-family tyrosine kinases, which are inhibited by tyrosine phosphorylation in their c-termini, suggesting a mechanism for signaling by CD45.
Product Information
Format
Unpurified
Control
Jurkat lysates
Presentation
Rabbit Monoclonal in buffer containing 50 mM Tris-Glycine (pH 7.4), 0.15 M NaCl containing 40% Glycerol, 0.01% sodium azide and 0.05% BSA.
Applications
Application
Please note that this product will not be available for sale after March 15, 2015. Please select one of the other antibodies against this target. Detect CD45 (C-term) using this Anti-CD45 (C-term) Antibody, clone EP322Y, Rabbit validated for use in WB, FC.
Key Applications
Flow Cytometry
Western Blotting
Application Notes
Flow Cytometry Analysis:
Flow cytometric analysis of permeabilized Jurkat cells using anti-CD45.
Biological Information
Immunogen
Synthetic peptide corresponding to residues in the C-terminal domain of human CD45.
Epitope
C-terminus
Clone
EP322Y
Host
Rabbit
Specificity
This antibody recognizes CD45 at and around the C-terminus.
The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP contains an extracellular domain, a single transmembrane segment and two tandem intracytoplasmic catalytic domains, and thus belongs to receptor type PTP. This gene is specifically expressed in hematopoietic cells. This PTP has been shown to be an essential regulator of T- and B-cell antigen receptor signaling. It functions through either direct interaction with components of the antigen receptor complexes, or by activating various Src family kinases required for the antigen receptor signaling. This PTP also suppresses JAK kinases, and thus functions as a regulator of cytokine receptor signaling. Four alternatively spliced transcripts variants of this gene, which encode distinct isoforms, have been reported. [provided by RefSeq].
FUNCTION:Required for T-cell activation through the antigen receptor. The first PTPase domain has enzymatic activity, while the second one seems to affect the substrate specificity of the first one. Upon T-cell activation, recruits an dephosphorylates SKAP1 and FYN. Ref.6 Ref.8
Catalytic activity Protein tyrosine phosphate + H2O = protein tyrosine + phosphate.
SUBUNIT STRUCTURE:Binds GANAB and PRKCSH By similarity. Interacts with SKAP1.
SUBCELLULAR LOCATION:Membrane; Single-pass type I membrane protein.
DOMAIN:The first PTPase domain interacts with SKAP1.
PTM: Heavily N- and O-glycosylated.
DISEASE:Defects in PTPRC are a cause of severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-positive/NK-cell-positive (T-B+NK+SCID) [MIM:608971]. SCID refers to a genetically and clinically heterogeneous group of rare congenital disorders characterized by impairment of both humoral and cell-mediated immunity, leukopenia, and low or absent antibody levels. Patients with SCID present in infancy with recurrent, persistent infections by opportunistic organisms. The common characteristic of all types of SCID is absence of T-cell-mediated cellular immunity due to a defect in T-cell development. Ref.14
Genetic variations in PTPRC are involved in multiple sclerosis susceptibility (MS) [MIM:126200]. MS is a neurodegenerative disorder characterized by the gradual accumulation of focal plaques of demyelination particularly in the periventricular areas of the brain. Peripheral nerves are not affected. Onset usually in third or fourth decade with intermittent progression over an extended period. The cause is still uncertain. Ref.13
SEQUENCE SIMILARITY:Belongs to the protein-tyrosine phosphatase family. Receptor class 1/6 subfamily.
Contains 2 fibronectin type-III domains.
Contains 2 tyrosine-protein phosphatase domains.
Product Usage Statements
Quality Assurance
Evaluated by Western Blotting on Jurkat cell lysates.
Western Blotting Analysis:
1:5,000 - 10,000 dilution of this antibody was used to detect CD45 in Jurkat cell lysate.
Usage Statement
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Storage and Shipping Information
Storage Conditions
Stable for 1 year at -20ºC from date of receipt.
Handling Recommendations: Upon receipt, and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles, which may damage IgG and affect product performance. Note: Variability in freezer temperatures below -20°C may cause glycerol containing solutions to become frozen during storage.
protein tyrosine phosphatase, receptor type, c polypeptide
CD45 antigen
T200 glycoprotein
T200 leukocyte common antigen
leukocyte-common antigen
protein tyrosine phosphatase, receptor type, C
receptor type
C
Background Information
CD45 is a receptor-tyrosine phosphatase required for antigen-induced signaling in T-cells and B-cells; its substrates are unknown. Interestingly, it associates with several Src-family tyrosine kinases, which are inhibited by tyrosine phosphorylation in their c-termini, suggesting a mechanism for signaling by CD45.
Product Information
Format
Unpurified
Control
Jurkat lysates
Presentation
Rabbit Monoclonal in buffer containing 50 mM Tris-Glycine (pH 7.4), 0.15 M NaCl containing 40% Glycerol, 0.01% sodium azide and 0.05% BSA.
Applications
Application
Please note that this product will not be available for sale after March 15, 2015. Please select one of the other antibodies against this target. Detect CD45 (C-term) using this Anti-CD45 (C-term) Antibody, clone EP322Y, Rabbit validated for use in WB, FC.
Key Applications
Flow Cytometry
Western Blotting
Application Notes
Flow Cytometry Analysis:
Flow cytometric analysis of permeabilized Jurkat cells using anti-CD45.
Biological Information
Immunogen
Synthetic peptide corresponding to residues in the C-terminal domain of human CD45.
Epitope
C-terminus
Clone
EP322Y
Host
Rabbit
Specificity
This antibody recognizes CD45 at and around the C-terminus.
The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP contains an extracellular domain, a single transmembrane segment and two tandem intracytoplasmic catalytic domains, and thus belongs to receptor type PTP. This gene is specifically expressed in hematopoietic cells. This PTP has been shown to be an essential regulator of T- and B-cell antigen receptor signaling. It functions through either direct interaction with components of the antigen receptor complexes, or by activating various Src family kinases required for the antigen receptor signaling. This PTP also suppresses JAK kinases, and thus functions as a regulator of cytokine receptor signaling. Four alternatively spliced transcripts variants of this gene, which encode distinct isoforms, have been reported. [provided by RefSeq].
FUNCTION:Required for T-cell activation through the antigen receptor. The first PTPase domain has enzymatic activity, while the second one seems to affect the substrate specificity of the first one. Upon T-cell activation, recruits an dephosphorylates SKAP1 and FYN. Ref.6 Ref.8
Catalytic activity Protein tyrosine phosphate + H2O = protein tyrosine + phosphate.
SUBUNIT STRUCTURE:Binds GANAB and PRKCSH By similarity. Interacts with SKAP1.
SUBCELLULAR LOCATION:Membrane; Single-pass type I membrane protein.
DOMAIN:The first PTPase domain interacts with SKAP1.
PTM: Heavily N- and O-glycosylated.
DISEASE:Defects in PTPRC are a cause of severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-positive/NK-cell-positive (T-B+NK+SCID) [MIM:608971]. SCID refers to a genetically and clinically heterogeneous group of rare congenital disorders characterized by impairment of both humoral and cell-mediated immunity, leukopenia, and low or absent antibody levels. Patients with SCID present in infancy with recurrent, persistent infections by opportunistic organisms. The common characteristic of all types of SCID is absence of T-cell-mediated cellular immunity due to a defect in T-cell development. Ref.14
Genetic variations in PTPRC are involved in multiple sclerosis susceptibility (MS) [MIM:126200]. MS is a neurodegenerative disorder characterized by the gradual accumulation of focal plaques of demyelination particularly in the periventricular areas of the brain. Peripheral nerves are not affected. Onset usually in third or fourth decade with intermittent progression over an extended period. The cause is still uncertain. Ref.13
SEQUENCE SIMILARITY:Belongs to the protein-tyrosine phosphatase family. Receptor class 1/6 subfamily.
Contains 2 fibronectin type-III domains.
Contains 2 tyrosine-protein phosphatase domains.
Product Usage Statements
Quality Assurance
Evaluated by Western Blotting on Jurkat cell lysates.
Western Blotting Analysis:
1:5,000 - 10,000 dilution of this antibody was used to detect CD45 in Jurkat cell lysate.
Usage Statement
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Storage and Shipping Information
Storage Conditions
Stable for 1 year at -20ºC from date of receipt.
Handling Recommendations: Upon receipt, and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles, which may damage IgG and affect product performance. Note: Variability in freezer temperatures below -20°C may cause glycerol containing solutions to become frozen during storage.
京公网安备11010802025653 版权所有：北京逸优科技有限公司
